You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis
|
---|---|
Published in |
PLOS ONE, March 2012
|
DOI | 10.1371/journal.pone.0033236 |
Pubmed ID | |
Authors |
Katja M. Hakkarainen, Khadidja Hedna, Max Petzold, Staffan Hägg |
Abstract |
Numerous observational studies suggest that preventable adverse drug reactions are a significant burden in healthcare, but no meta-analysis using a standardised definition for adverse drug reactions exists. The aim of the study was to estimate the percentage of patients with preventable adverse drug reactions and the preventability of adverse drug reactions in adult outpatients and inpatients. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 58% |
Italy | 1 | 8% |
Canada | 1 | 8% |
Unknown | 3 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 83% |
Practitioners (doctors, other healthcare professionals) | 2 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 282 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 2 | <1% |
United States | 2 | <1% |
Colombia | 1 | <1% |
Canada | 1 | <1% |
Germany | 1 | <1% |
Spain | 1 | <1% |
Belgium | 1 | <1% |
Unknown | 273 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 43 | 15% |
Researcher | 36 | 13% |
Student > Ph. D. Student | 36 | 13% |
Student > Bachelor | 26 | 9% |
Student > Postgraduate | 25 | 9% |
Other | 60 | 21% |
Unknown | 56 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 89 | 32% |
Pharmacology, Toxicology and Pharmaceutical Science | 59 | 21% |
Biochemistry, Genetics and Molecular Biology | 12 | 4% |
Agricultural and Biological Sciences | 12 | 4% |
Nursing and Health Professions | 11 | 4% |
Other | 30 | 11% |
Unknown | 69 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2021.
All research outputs
#1,735,030
of 25,837,817 outputs
Outputs from PLOS ONE
#21,206
of 224,660 outputs
Outputs of similar age
#9,335
of 172,295 outputs
Outputs of similar age from PLOS ONE
#313
of 3,596 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 224,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,295 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 3,596 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.